Boston, MANCT06360900Now EnrollingIRB Ready

Functional Dyspepsia Clinical Trial in Boston, MA

Access cutting-edge functional dyspepsia treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.

Sponsored by Spaulding Rehabilitation Hospital

Quick Self-Assessment

See if you qualify for this Boston location

Preparing your pre-screening questions…

Expert Care in Boston

Access functional dyspepsia specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related functional dyspepsia treatment provided free

Apply for This Boston Location

Check if you qualify for this functional dyspepsia clinical trial in Boston, MA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Boston

    Convenient for MA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Boston site if eligible
  4. 4Begin participation

About This Functional Dyspepsia Study in Boston

The study aims at evaluating physiological and patient-reported outcomes for a dual intervention approach including a stimulation device and support therapy in patients with functional dyspepsia.

Sponsor: Spaulding Rehabilitation Hospital

Who Can Participate

Inclusion Criteria

Age 18-65 years old (inclusive)
Ability to give written consent and participate in behavioral intervention in English
Willingness to attend weekly treatment sessions over live video, daily self-administered transcutaneous auricular vagus nerve stimulation (taVNS) sessions, and engage in homework during treatment
Avoidance of alcohol, nicotine, and caffeine for 24 hours prior to study session
Diagnosis according to the Rome IV criteria for both epigastric pain syndrome and postprandial distress syndrome subtypes
Stable medical treatment for functional dyspepsia (FD) during 1 month before the study and during the study period

Exclusion Criteria

Previous receipt of cognitive behavioral therapy (CBT) for gastrointestinal symptoms
Enteral or parenteral feeding
Previous gastrointestinal surgery, electrolyte disturbances, kidney dysfunction, renal insufficiency, or iron overload disorders
Estimated Glomerular Filtration Rate (eGFR) \< 60
Medications that affect gastrointestinal motility in addition to medications or products containing tetrahydrocannabinol (THC) will be stopped at least 7 days prior to the start of the study and for the duration of the study. However, anti-depressants (SSRI's, TCA's) may be allowed in order to reduce the risk of worsening neuropsychiatric disease, though it will be up to the study team and the Principal Investigator whether subjects on anti-depressants will be able to participate in the study
Intellectual disability by history
Diabetes, mitochondrial disease, severe autonomic dysfunction, and small fiber polyneuropathy
No active clinical acupuncture therapy
Illicit drugs or opioid usage
History of arrhythmias
Current pregnancy/breastfeeding
Contraindications for magnetic resonance imaging (MRI) (implanted ferromagnetic objects, claustrophobia)
Weight \> 450 lbs. (limit of the MRI table)
Allergy to pineapple (used in the test meal during MRI)
Any other condition interfering with study requirements, according to the Investigator

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Boston?

Yes, this clinical trial (NCT06360900) has an active research site in Boston, MA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Functional Dyspepsia Treatment Options in Boston, MA

If you're searching for functional dyspepsia treatment options in Boston, MA, this clinical trial (NCT06360900) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced functional dyspepsia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all functional dyspepsia clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Boston, MA

See all pulmonary embolism clinical trials recruiting in Boston — not just this study.

Browse Pulmonary Embolism Trials in Boston →

Browse More Trials by Condition

Pulmonary Embolism TrialsAll Conditions →

Ready to Join in Boston?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Boston, MA